<code id='82AB3F5C21'></code><style id='82AB3F5C21'></style>
    • <acronym id='82AB3F5C21'></acronym>
      <center id='82AB3F5C21'><center id='82AB3F5C21'><tfoot id='82AB3F5C21'></tfoot></center><abbr id='82AB3F5C21'><dir id='82AB3F5C21'><tfoot id='82AB3F5C21'></tfoot><noframes id='82AB3F5C21'>

    • <optgroup id='82AB3F5C21'><strike id='82AB3F5C21'><sup id='82AB3F5C21'></sup></strike><code id='82AB3F5C21'></code></optgroup>
        1. <b id='82AB3F5C21'><label id='82AB3F5C21'><select id='82AB3F5C21'><dt id='82AB3F5C21'><span id='82AB3F5C21'></span></dt></select></label></b><u id='82AB3F5C21'></u>
          <i id='82AB3F5C21'><strike id='82AB3F5C21'><tt id='82AB3F5C21'><pre id='82AB3F5C21'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:leisure time    Page View:52381
          A venomous West African Green Mamba snake
          Mark Ralston/AFP/Getty Images

          Antivenom, like Mexican Coke or grandma’s cookies, is still made the old-fashioned way. In antivenom’s case, the recipe is straightforward: Pump a horse full of sub-lethal doses of venom from various local snakes, wait for them to develop an immune response, tap their blood, purify out antibodies, bottle, and freeze.

          This vampiric, century-old process still reigns because of the unique scientific challenge posed by snake venoms. Researchers are skilled at making antibodies in the lab against specific targets. But venoms can vary vastly. A viper induces “circulatory shock” by shredding proteins in your blood, whereas a mamba blocks receptors on your muscles, paralyzing you. A king cobra seems to have multiple methods of murder. How do you build a drug against them all?

          advertisement

          “Snake venom is one of the most complex things you can come across,” said Kartik Sunagar, head of the Evolutionary Venomics Lab in Bengaluru, India. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          The drug industry sees a key ally in the Senate prevail
          The drug industry sees a key ally in the Senate prevail

          NorthCarolinaSenatorRichardBurrreceivedstrongsupportfromthebiotechsector.GerryBroome/APWASHINGTON—Av

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          TytoCare raises $49 million to build out AI

          AdobeYou’rereadingthewebeditionofSTATHealthTech,ourguidetohowtechistransformingthelifesciences. Sign